Patent applications and USPTO patent grants for PRIMEX CLINICAL LABORATORIES, INC..The latest application filed is for "variable epitope library compositions and methods of therapeutic and prophylactic use".
Patent | Date |
---|---|
Variable epitope library compositions and methods of therapeutic and prophylactic use Grant 10,383,927 - Manucharyan , et al. A | 2019-08-20 |
Variable Epitope Library Compositions And Methods Of Therapeutic And Prophylactic Use App 20160199471 - Manucharyan; Karen ;   et al. | 2016-07-14 |
Compositions and methods for alzheimer's disease Grant 8,394,380 - Manucharyan , et al. March 12, 2 | 2013-03-12 |
Compositions And Methods For Alzheimer's Disease App 20110065654 - Manucharyan; Karen ;   et al. | 2011-03-17 |
Compositions and methods for Alzheimer's disease Grant 7,846,892 - Manucharyan , et al. December 7, 2 | 2010-12-07 |
Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases App 20090214591 - Manucharyan; Karen ;   et al. | 2009-08-27 |
NCAGE Code | 7JZX2 | PRIMEX CLINICAL LABORATORIES, INC. |
CAGE Code | 7JZX2 | PRIMEX CLINICAL LABORATORIES, INC. |
S.A.M. Registration | 7JZX2 [943665794] | PRIMEX CLINICAL LABORATORIES, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.